GLP1-S
BW1-S (Semaglutide)
Available Vial Sizes: 5 mg, 10 mg, 20 mg and 30mg in a 3 mL vial
Semaglutide is a long-acting synthetic analog of glucagon-like peptide-1 (GLP-1), a naturally occurring incretin hormone. It is extensively studied as a potent GLP-1 receptor agonist for its effects on metabolic regulation, glucose homeostasis, and appetite control in laboratory and animal models.
In research settings, semaglutide has demonstrated significant impacts on slowing gastric emptying, enhancing insulin secretion in a glucose-dependent manner, suppressing glucagon release, and reducing food intake. These properties make it a valuable tool for investigating weight management, type 2 diabetes pathways, cardiovascular health, and broader metabolic disorders.
This compound is offered strictly for research use only (RUO)